NCT02078648 2025-02-03Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma MultiformeStemline Therapeutics, Inc.Phase 1/2 Completed74 enrolled 19 charts
NCT01403285 2014-05-19Peptide-based Glioma Vaccine IMA950 in Patients With GlioblastomaImmatics Biotechnologies GmbHPhase 1 Terminated6 enrolled